On June 16, Health 160 (02656.HK) declined 8.43% in regular trading, trading at HK$11.72/share, with turnover of HK$43.82 million.
Within the Health Care Distributors sector where Health 160 belongs, the overall sector showed broad weakness. Among individual stocks, Sinopharm down 0.53%, Shanghai Pharma down 0.67%, Baiyunshan Ph down 1.71%, YSB up 0.32%, ETHK Labs Inc down 14.12%.
Health 160 International Limited is an investment holding company primarily engaged in pharmaceutical sales. The company operates two main business segments: pharmaceutical and health product sales through wholesale and retail models, and digital healthcare solutions including online marketing solutions, digital hospital solutions, and online health services. The company operates the Health 160 platform and primarily conducts business in mainland China.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)